Spanish Initiative for the Automation in Urban Transport: AutoMOST

The progressive automation of transport will imply a new paradigm in mobility, which will profoundly affect people, logistics of goods, as well as other sectors dependent on transport. It is precise within this automation where the development of new driving technologies is going to cause a great impact on the mobility of the near future, and that will have an effect on the economic, natural and social environment. It is therefore a primary issue at the global level, as it is reflected in the work programs of the European Commission in relation to the road transport [1] [2]. Thus, the size impact is caused by the following novelties and advantages: 1) Safety: Accidents reduction caused by human error; 2) Efficiency increase in transportation, both in energy consumption and time; 3) Comfort for users and professionals who will increase their operational availability to execute other more valuable tasks, both for them and enterprises; 4) Social Inclusion: enabling mobility easily for everybody during more time; 5) Accessibility, to get to city centers and other difficult reach places. It should be noted that the economic impact projected for automated driving for the years to come ranges up to €71 bn in 2030, when estimated global market for automated vehicles is 44 million vehicles, as is reflected in document Automated Driving Roadmap by ERTRAC [3], European Road Transport Research Advisory Council (http://www.ertrac.org/uploads/documentsearch/id38/ERTRAC_Automated-Driving-2015.pdf). As background that already anticipates these im-provements, the Advance Driver Assistance System (ADAs) have already showed the safety increase in the last ten years, but always maintain a leading role for the driver. Related to the efficiency increase, automated driving offers great opportunities for those companies where mobility is a key factor in operating costs, and affects the whole value chain. The project opportunity is consistent with ERTRAC vision, especially in applications focused on the urban environment [4], where it is expected a deployment of the technology of high level automation in an immediate future. This is possible by the potential to incorporate smart infrastructure to improve guidance and positioning, as well as lower speed, which eases its progressive deployment. The objective of AutoMOST is developing technologies for the automation of vehicles in urban transport and industrial applications, to increase significantly the efficiency, safety and environmental sustainability. More specifically, AutoMOST will allow the implementation of shared control systems (Dual-Mode) [5] for future automated vehicles that allow the services operate more efficiently and flexibly, in a context of intelligent and connected infrastructures.This work is supported by the Centre for the Development of Industrial Technology (CDTI) through the CIEN (Consorcios de Investigación Empresarial Nacional) Spanish program. So, the authors would like to thank the CDTI which is a Public Business Entity, answering to the Ministry of Economy and Competitiveness in Spain, which fosters the technological development and innovation of Spanish companies. It is the entity that channels the funding and support applications for national and international R&D&I projects of Spanish companies

ESC observations of SN 2005cf: II. Optical Spectroscopy and the high velocity features

The ESC-RTN optical spectroscopy data-set for SN 2005cf is presented and analyzed. The observations range from -11.6 and +77.3 days with respect to B-band maximum light. The evolution of the spectral energy distribution of SN 2005cf is characterized by the presence of high velocity SiII and CaII features. SYNOW synthetic spectra are used to investigate the ejecta geometry of silicon. Based on the synthetic spectra the SiII high velocity feature appears detached at 19500 km/s. We also securely establish the presence of such feature in SN 1990N, SN 1994D, SN 2002er and SN 2003du. On a morphological study both the CaII IR Triplet and H&K absorption lines of SN 2005cf show high velocity features centered around 24000 km/s. When compared with other Type Ia SNe based on the scheme presented in Benetti et al. 2005 SN 2005cf definitely belongs to the LVG group.Comment: A&A accepted for publicatio

Differential Effects of Antibiotic Therapy on the Structure and Function of Human Gut Microbiota

The human intestinal microbiota performs many essential functions for the host. Antimicrobial agents, such as antibiotics (AB), are also known to disturb microbial community equilibrium, thereby having an impact on human physiology. While an increasing number of studies investigate the effects of AB usage on changes in human gut microbiota biodiversity, its functional effects are still poorly understood. We performed a follow-up study to explore the effect of ABs with different modes of action on human gut microbiota composition and function. Four individuals were treated with different antibiotics and samples were taken before, during and after the AB course for all of them. Changes in the total and in the active (growing) microbiota as well as the functional changes were addressed by 16S rRNA gene and metagenomic 454-based pyrosequencing approaches. We have found that the class of antibiotic, particularly its antimicrobial effect and mode of action, played an important role in modulating the gut microbiota composition and function. Furthermore, analysis of the resistome suggested that oscillatory dynamics are not only due to antibiotic-target resistance, but also to fluctuations in the surviving bacterial community. Our results indicated that the effect of AB on the human gut microbiota relates to the interaction of several factors, principally the properties of the antimicrobial agent, and the structure, functions and resistance genes of the microbial community

Derivative estimation for longitudinal data analysis

In a previous paper we derived equivalence relations for pseudo-Wronskian determinants of Hermite polynomials. In this paper we obtain the analogous result for Laguerre and Jacobi polynomials. The equivalence formulas are richer in this case since rational Darboux transformations can be defined for four families of seed functions, as opposed to only two families in the Hermite case. The pseudo-Wronskian determinants of Laguerre and Jacobi type will thus depend on two Maya diagrams, while Hermite pseudo-Wronskians depend on just one Maya diagram. We show that these equivalence relations can be interpreted as the general transcription of shape invariance and specific discrete symmetries acting on the parameters of the isotonic oscillator and Darboux-Poschl-Teller potential.UK Medical Research Council, Grant/Award Numbers: MR/M020894/1, MC_UU_12013/7 MC_UU_12013/5; Wellcome Trust, Grant/Award Numbers:WT087997MA and 102215/2/13/2; Spanish Ministry of Economy and Competitiveness, Grant/Award number: MTM2014‐52184; National Institute forHealth Research (NIHR), Grant/AwardNumber: NF‐SI‐0611‐10196; University ofBristol; British Heart Foundation, Grant/Award Number: SP/07/008/24066; USNIH, Grant/Award Number: R01 DK07765

BMI peak in infancy as a predictor for later BMI in the Uppsala Family Study.

BACKGROUND: The development of obesity through childhood, often characterized by using body mass index (BMI), has received much recent interest because of the rapidly increasing levels of obesity worldwide. However, the extent to which the BMI trajectory in the first year of life (the BMI 'peak' in particular) is associated with BMI in later childhood has received little attention. SUBJECTS: The Uppsala Family Study includes 602 families, comprising mother, father and two consecutive singleton offspring, both of whom were delivered at the Uppsala Academic Hospital, Sweden, between 1987 and 1995. The children's postnatal growth data, including serial measurements of height and weight (from which BMI was calculated), were obtained from health records. All children had a physical examination when they were aged between 5 and 13 years, at which height and weight were again recorded and used to calculate age- and sex-adjusted BMI z-scores. METHODS: Subject-specific growth curves were fitted to the infant BMI data using penalized splines with random coefficients, and from these the location of the BMI peak for each participant was estimated. A multilevel modelling approach was used to assess the relationships between the BMI peak and BMI z-score in later childhood. RESULTS: The BMI peak occurred, on average, slightly later in female children, with a higher BMI peak in male children. Considered separately, both age and BMI at BMI peak were positively associated with later BMI z-score. Considered jointly, both dimensions of BMI peak retained their positive associations. CONCLUSIONS: The growth trajectory associated with higher childhood BMI appears to include a later and/or higher BMI peak in infancy

Predictores de éxito del tratamiento con cánula nasal de alto flujo en el fallo respiratorio agudo hipoxémico.

High-flow nasal cannula (HFNC) therapy is used in the treatment of acute respiratory failure (ARF) and is both safe and effective in reversing hypoxemia. In order to minimize mortality and clinical complications associated to this practice, a series of tools must be developed to allow early detection of failure. The present study was carried out to: (i)examine the impact of respiratory rate (RR), peripheral oxygen saturation (SpO2), ROX index (ROXI=[SpO2/FiO2]/RR) and oxygen inspired fraction (FiO2) on the success of HFNC in patients with hypoxemic ARF; and (ii)analyze the length of stay and mortality in the ICU, and the need for mechanical ventilation (MV). A retrospective study was carried out in the medical-surgical ICU of Hospital de Montilla (Córdoba, Spain). Patients diagnosed with hypoxemic ARF and treated with HFNC from January 2016 to January 2018 were included. Out of 27 patients diagnosed with ARF, 19 (70.37%) had hypoxemic ARF. Fifteen of them (78.95%) responded satisfactorily to HFNC, while four (21.05%) failed. After two hours of treatment, RR proved to be the best predictor of success (area under the ROC curve [AUROC] 0.858; 95%CI: 0.63-1.05; P=.035). For this parameter, the optimal cutoff point was 29rpm (sensitivity 75%, specificity 87%). After 8hours of treatment, FiO2 and ROXI were reliable predictors of success (FiO2: AUROC 0.95; 95%CI: 0.85-1.04; P=.007 and ROXI: AUROC 0.967; 95%CI: 0.886-1.047; P=.005). In the case of FiO2 the optimal cutoff point was 0.59 (sensitivity 75%, specificity 93%), while the best cutoff point for ROXI was 5.98 (sensitivity 100%, specificity 75%). Using a Cox regression model, we found RR5.98 after 8hours of treatment, to be associated with a lesser risk of MV (RR: HR 0.103; 95%CI: 0.11-0.99; P=.05; FiO2: HR 0.053; 95%CI: 0.005-0.52; P=.012; and ROXI: HR 0.077; 95%CI: 0.008-0.755; P=.028, respectively). RR after two hours of treatment, and FiO2 and ROXI after 8hours of treatment, were the best predictors of success of HFNC. RR5.98 were associated with a lesser risk of MV

Crohn's disease and Sweet's syndrome: an uncommon association Enfermedad de Crohn y síndrome de Sweet: una asociación infrecuente

Sweet's syndrome or acute febrile neutrophilic dermatosis (SS) is characterized by the sudden onset of painful erythematous lesions (papules, nodules, and plaques) together with fever and neutrophilia. The lesions are typically located on hands, arms, upper trunk, neck and face, showing an asymmetric distribution. Acute phase reactants are usually elevated and dermal infiltration of neutrophils without vasculitis is seen on skin biopsies. It is considered as a marker of systemic disease in over half of the cases, and is associated with infections, inflammatory bowel disease, autoimmune connective tissue disorders and various neoplasias. Its association with Crohn's disease (CD) is unusual and it appears mainly in association with colonic involvement. Fewer than 50 cases have been published in the medical literature since its first description in 1964, some concurrent with the first episode of CD. We present two patients with Crohn's disease and Sweet's syndrome diagnosed in our department at the time of CD diagnosis, as well as their response to treatment, subsequent course of the disease, and a review of the scientific literature.El síndrome de Sweet o dermatosis neutrofílica febril aguda (SS) se caracteriza por la aparición brusca de lesiones eritematosas, (pápulas, nódulos y placas) dolorosas, junto con fiebre y neutrofilia, siendo de presentación poco frecuente. Las lesiones se localizan preferentemente en manos, brazos, parte superior del tronco, cuello y cara, con distribución asimétrica. Suele haber elevación de reactantes de fase aguda y en las biopsias cutáneas se identifica una infiltración dérmica de neutrófilos sin vasculitis. Se considera un marcador de enfermedad sistémica en más de la mitad de los casos, asociándose a infecciones, enfermedad inflamatoria intestinal, conectivopatías autoinmunes y diversas neoplasias. Su asociación con la enfermedad de Crohn (EC) es poco habitual, asociado sobre todo a afectación colónica. Se han publicado menos de 50 casos en la literatura médica desde su primera descripción en 1964, algunos de ellos simultáneos con el primer brote de la EC. Presentamos dos pacientes con enfermedad de Crohn y síndrome de Sweet diagnosticados en nuestro servicio en el momento del diagnóstico de la EC, así como su respuesta al tratamiento, evolución posterior y revisión de la literatura científica